CAS 317318-70-0 Fat Loss Sarms White Solid Cardarine GW501516 GSK - 516

Brand Name:HW SARMs Raw Powder Cardarine GW501516
Model Number:
SARMs Raw Powder Cardarine GW501516
Place of Origin:China
Certification:GMP,SGS,UKAS,ISO
Min.Order Quantity:Negotiable
Price:Negotiable
Packaging Details:foil bag or as your requirement
Delivery Time:Within 1-2 working days upon receipt payment
Payment Terms:T/T, Western union, MoneyGram
Supply Ability:1000kgs/month

Product Details

Purity:	99%	MF.:	C21H18F3NO3S2	MW.:	453.5
Appearance:	white solid	Flash point:	307.321ºC	Function:	Selective Androgen Receptor Modulators powder
Keywords:	CAS 317318-70-0 USP Grade SARMs Steroids / Bodybuilding Oral Steroids GW 501516 Cardarine, SARM Steroids, SARM Steroids from China, SARM Steroids for sale

Product Description

SARMs Raw Powder Cardarine GW501516 GSK-516 Endurobol SARM Fat Loss

Basic Info:
Product Name: GW501516
CAS NO.: 317318-70-0
Alias: Cardarine
Molecular formula: C21H18F3NO3S2
Molecular weight: 453.50
Purity: 99%
Grade: Pharmaceutical Grade
Appearance: White Powder
Usage: Fat loss
Dose: The recommended dosage for GW is 10-20 mg and for 8 weeks length

COA:

Test Items	Specification	Results
Description	: White Crystalline Powder	White Crystalline Powder
Identification	: Positive	Positive
Assay(by HPLC)	: 98.0~102.0%	99.84%
Absorbance(E1cm)	: 465~495	482.5
Melting Point	: 191~195¡ãC	193.5~195.0¡ãC
Loss On Drying	: 0.5%max	0.19%
Specific Rotation	: +288¡ã~ +298¡ã	+290.2¡ã
Residue On Ignition	: 0.1%max	0.03%
Related Substances	: Total:1.5%max	<1.3%
	Single:0.5%max	<0.4%
Residue Solvents	: 0.2%max	0.10%
Heavy Metals	: 20PPm max	<10PPm
Conclusion	The specification conform with enterprise standard.

GW-501516
GW-501516, better known as Cardarine, is a unique medication officially classified as a PPAR receptor agonist (PPAR-RA). Research for this medication began in 1992 in a conjoined effort between GlaxoSmithKline (GSK) and Ligand Pharmaceuticals. Research into this product was set forth in an effort to provide treatment for various cardiovascular diseases, as well as diabetes, obesity and other conditions. It was soon discovered that the PPAR-RA was highly effective at enhancing endurance, but it was also shown to carry a high potential cost. It was discovered that Cardarine increased the chances of cancer significantly, and as a result, GSK dropped all further research. However, the studies that produced cancerous results used doses of Cardarine that were 500 to even 1000 times the amount that a human being would take. If cancer is a risk with standard dosing is unknown.